Overview
Also known as:
FDA & Trial Timeline
10 eventsAffiliated Hospital to Academy of Military Medical Sciences — EARLY_PHASE1
Affiliated Hospital to Academy of Military Medical Sciences — EARLY_PHASE1
Institute of Hematology & Blood Diseases Hospital, China — PHASE2
Chinese PLA General Hospital — EARLY_PHASE1
Genrix (Shanghai) Biopharmaceutical Co., Ltd. — PHASE2
Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
Shenzhen Geno-Immune Medical Institute — PHASE1, PHASE2
Shanghai Zhongshan Hospital
Peking Union Medical College Hospital — PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Plasmacytoma.
7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Plasmacytoma.
Community
No community posts yet. Be the first to share your experience with Plasmacytoma.
Start the conversation →Latest news about Plasmacytoma
Disease timeline:
New recruiting trial: Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: GR1803 Injection in Patients With RRMM
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: The Indiana Myeloma Registry
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
A new clinical trial is recruiting patients for Plasmacytoma
New recruiting trial: Longitudinal Data Registry of Plasma Cell Dyscrasia
A new clinical trial is recruiting patients for Plasmacytoma
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Plasmacytoma
Are there clinical trials for Plasmacytoma?
Yes — 7 recruiting clinical trials are currently listed for Plasmacytoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Plasmacytoma?
25 specialists and care centers treating Plasmacytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.